---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-038729"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T08:55:27.218365+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BrainStorm FY2022 net loss $24.3M; cash drops to $3M; FDA ADCOM for NurOwn BLA

## Summary
- Net loss of $24.3M ($0.66 per share) vs $24.5M ($0.68) in 2021; no revenue.
- Cash and short-term deposits fell to $3M from $22M at year-end 2021.
- R&D expenses $14M, G&A $10.9M; combined $24.9M operating spend.
- FDA will hold Advisory Committee meeting to review NurOwn BLA for ALS; File over Protest used.
- Dr. Stacy Lindborg promoted to Co-CEO in January 2023.

## SEC filing metadata
- accession: 0001104659-23-038729
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465923038729/0001104659-23-038729-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465923038729/tm2310964d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-038729
- JSON: https://secwatch.observer/filing/0001104659-23-038729.json
- Plain text: https://secwatch.observer/filing/0001104659-23-038729.txt

## Key facts
- Earnings Releases
  BRAINSTORM CELL THERAPEUTICS INC. reported the fiscal year ended December 31, 2022 results: net income approximately $30.3 million.
  - Period: the fiscal year ended December 31, 2022
  - Net income: approximately $30.3 million
  - Result: reported results
  source text: Net loss for the twelve months ended December 31, 2022, was approximately $
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465923038729/0001104659-23-038729-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.